Terapias cuádruples son superiores a terapia triple estándar en primera línea de erradicación de Helicobacter pylori en Chile

Reyes, Diego; Ortiz, Javier; Fuentes-López, Eduardo; Budnik, Sigall; Gándara, Vicente; Gallardo, Andrea; Seydewitz, María Francisca; Candia, Roberto; Vargas, José Ignacio; Rollan, María Paz.
Gastroenterol. hepatol. (Ed. impr.) ; 45(7): 515-523, Ago - Sep 2022. graf, tab
Artigo em Espanhol | IBECS (Espanha) | ID: ibc-206910

Documentos relacionados

  1. Quadruple therapies are superior to standard triple therapy for Helicobacter pylori first-line eradication in Chile.
  2. Ilaprazole-amoxicillin dual therapy at high dose as a first-line treatment for helicobacter pylori infection in Hainan: a single-center, open-label, noninferiority, randomized controlled trial.
  3. Efficacy of 7-day Tailored Therapy for <i>Helicobacter pylori</i> Eradication based on Clarithromycin Resistance.
  4. Meta-analysis of Helicobacter pylori eradication therapy using vonoprazan as an acid suppressor compared with bismuth quadruple therapy.
  5. [SUMMARY OF THE ISRAEL GASTROENTEROLOGY ASSOCIATION (IGA) GUIDELINES FOR THE MANAGEMENT AND TREATMENT OF HELICOBACTER PYLORI IN 2019].
  6. Comparative study of Helicobacter pylori eradication rates of concomitant therapy vs modified quadruple therapy comprising proton-pump inhibitor, bismuth, amoxicillin, and metronidazole in Korea.
  7. Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infection.
  8. Adherence to international guidelines for the management of Helicobacter pylori infection among gastroenterologists and gastroenterology fellows in Italy: A Survey of the Italian Federation of Digestive Diseases - FISMAD.
  9. Comparison of vonoprazan dual therapy, quadruple therapy and standard quadruple therapy for Helicobacter pylori infection in Hainan: a single-center, open-label, non-inferiority, randomized controlled trial.
  10. Efficacy of genotypic susceptibility-guided tailored therapy for Helicobacter pylori infection: A systematic review and single arm meta-analysis.